Related Experiment Video

Updated: May 17, 2026

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
11:09

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals

Published on: December 16, 2022

Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment)

Małgorzata Kobylecka1, Joanna Mączewska, Katarzyna Fronczewska-Wieniawska

  • 1Nuclear Medicine Department Warsaw Medical University, Warsaw, Poland. makob@amwaw.edu.pl

Nuclear Medicine Review. Central & Eastern Europe
|October 11, 2012
PubMed

Insights

Assessing cardiac viability is key for revascularization success. Positron Emission Tomography (PET) offers accurate myocardial viability assessment, though combined PET/CT imaging enhances morphological evaluation.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Accurate assessment of myocardial viability is essential for patient selection for revascularization procedures.
  • Preoperative evaluation of viable myocardium predicts long-term cardiac event-free survival post-intervention.
  • Current modalities include echocardiography, cardiac molecular imaging (PET, SPECT), cardiovascular MR, and CT.

Purpose of the Study:

  • To describe the methods and challenges of myocardial viability assessment using 18-fluorodeoxyglucose Positron Emission Tomography (18FDG PET).
  • To highlight the accuracy and reproducibility of PET for evaluating myocardial ischemia and viability.
  • To discuss the integration of PET with computed tomography (CT) for enhanced diagnostic capabilities.

Main Methods:

  • Review of diagnostic approaches for myocardial viability assessment.
  • Focus on 18FDG PET imaging techniques and their limitations (e.g., resolution).
  • Description of combined PET/CT systems for integrated morphologic and metabolic assessment.

Main Results:

  • PET imaging demonstrates high accuracy and reproducibility in assessing myocardial ischemia and viability.
  • A key limitation of PET is its current resolution of approximately 0.4 cm.
  • PET/CT enables comprehensive assessments, including coronary calcium scoring and non-invasive coronary angiography.

Conclusions:

  • 18FDG PET is a valuable tool for myocardial viability assessment, crucial for guiding revascularization decisions.
  • The integration of PET with CT (PET/CT) overcomes some limitations and expands diagnostic utility.
  • Combined PET/CT offers a more complete evaluation of cardiac viability and coronary anatomy.

More Related Videos

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)10:02

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Published on: May 2, 2012

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...